Omvoh (Mirikizumab): A New Treatment for Inflammatory Bowel Disease
What Is Omvoh (Mirikizumab)? Omvoh is a monoclonal antibody specifically designed to target interleukin-23 (IL-23), a cytokine involved in the […]
FDA Approval
AVT02: A Promising Biosimilar Drug to Adalimumab (Humira)
Biosimilar drugs have emerged as a cost-effective alternative to their reference biologic counterparts. They offer the same therapeutic benefits while
Sotatercept for Pulmonary Arterial Hypertension
Sotatercept: A Game Changer for Merck and the Pulmonary Arterial Hypertension Market Introduction Sotatercept, a groundbreaking drug developed by Merck,
From Lab to Market: The Journey of a New Drug
From Lab to Market: The Journey of a New Drug Guide on the FDA’s new drug approval process From Lab